DIVINHEALSimplifying Global Wellbeing
HOME
TREATMENTS
HOSPITALS
Page background

Immunotherapy & CAR-T Cell Therapy Success Rate in Pune

Content updated at: February 19, 2026

About

Immunotherapy & CAR-T Cell Therapy Success Rates in Pune

Understanding the success rate of Immunotherapy & CAR-T Cell Therapy in Pune is vital for patients considering advanced cancer treatments. Outcomes are shaped by various factors, including the specific therapy, cancer type and stage, and individual patient characteristics. Pune, as a growing medical hub, provides these specialized treatments with a focus on evidence-based protocols.

Success and survival rates in Pune are typically reviewed through aggregated clinical data from various treatment centers and evaluated against established benchmarks. These outcome trends reflect careful patient selection, adherence to international guidelines, and available technological advancements. It is important to note that individual results can vary based on the unique patient profile.

Defining Success in Advanced Cancer Therapies

For Immunotherapy and CAR-T Cell Therapy, "success" encompasses various critical outcomes. This often includes achieving complete or partial remission, extending overall survival, enhancing progression-free survival, and improving the patient's quality of life. Understanding these differences between short-term responses and long-term recovery insights is crucial for patients and their families.

Immunotherapy & CAR-T Cell Therapy Success Rate Breakdown

Success rates for Immunotherapy & CAR-T Cell Therapy in Pune vary depending on the specific treatment approach and patient factors.

Treatment Type / Category Typical Use Case Success Rate Range (%) What Success Indicates
Checkpoint Inhibitor Immunotherapy Melanoma, Lung Cancer, Kidney Cancer 20%–45% Disease control, prolonged survival, or remission
CAR-T Cell Therapy (CD19-targeted) Certain types of Leukemia and Lymphoma 40%–70% High rates of complete remission, extended survival
Oncolytic Virus Immunotherapy Advanced Melanoma 15%–30% Localized tumor reduction, immune response activation
Adoptive Cell Therapy (TILs) Advanced Melanoma, other solid tumors (experimental) 25%–50% Tumor regression, durable responses

Stage Wise & Age Wise Immunotherapy & CAR-T Cell Therapy Survival Rate in Pune

The stage wise Immunotherapy & CAR-T Cell Therapy survival rate in Pune, much like global trends, shows significant variation depending on the cancer’s progression. Earlier stages generally correlate with better outcomes, allowing for more effective intervention. Additionally, the Immunotherapy & CAR-T Cell Therapy survival rate by age in Pune also varies, with younger, fitter patients often tolerating treatments better. These trends align with internationally observed clinical outcomes.

Age Group / Patient Category Cancer Stage (General) Success Rate Range (%)
Younger Adults (18-45 years) Early to Intermediate Stage 50%–75%
Middle-aged Adults (46-65 years) Early to Intermediate Stage 40%–65%
Older Adults (66+ years) Early to Intermediate Stage 25%–55%
All Ages Advanced/Metastatic Stage 15%–40%

Immunotherapy & CAR-T Cell Therapy Success Rate: Pune vs. Global Outcomes

Success rates for Immunotherapy & CAR-T Cell Therapy in Pune are often comparable with international standards when similar protocols, advanced technology, and rigorous patient selection criteria are applied. Leading centers such as AIIMS, Tata Memorial Centre, and major institutes follow evidence-based protocols.

Country Immunotherapy & CAR-T Cell Therapy Success Rate Range (%)
India (including Pune) 35%–65%
United States 40%–70%
United Kingdom 38%–68%
Germany 39%–69%
Singapore 37%–67%
South Korea 36%–66%
Australia 37%–67%

These success rates are indicative and can vary significantly based on individual patient conditions and the specific treatment approach. Outcomes are not guaranteed.

Factors Influencing Immunotherapy & CAR-T Cell Therapy Recovery Rate in Pune

  • The specific type and stage of cancer being treated.
  • Patient's overall health, age, and presence of co-morbidities.
  • Previous treatments received and their impact on immune function.
  • Genetic markers and molecular characteristics of the tumor.
  • Quality of care, including diagnostics, treatment adherence, and post-treatment monitoring.
  • Immune system responsiveness and potential for treatment-related toxicities.

Data Sources & Methodology for Outcome Assessment

  • Analysis of national cancer registries and institutional outcome databases.
  • Review of peer-reviewed medical studies published in scientific journals.
  • Aggregated multi-hospital outcome data focusing on specific cancer types.
  • Guidelines and reports from global health organizations like WHO and IARC.
  • Clinical trial results demonstrating efficacy and safety profiles.

Informed Decisions for Healthcare

Navigating complex treatment options requires clear, data-based information. Understanding the potential outcomes helps patients make well-informed choices about their healthcare journey.

Hospitals Offering this treatment

India offers premium medical procedures at affordable prices. Discover our most popular treatments, delivered by the country's finest doctors.

Artemis Hospital

Artemis Hospital

Private, semi-private, deluxe, and suite rooms
Super Speciality Hospital & Trauma Centre
View Details

Meet Our Doctors

Meet our team of highly qualified and experienced medical professionals dedicated to providing the best healthcare services.

Dr. Anjana Satyajit

Dr. Anjana Satyajit

Head - Dentistry

Dentistry

New Delhi

20+ Years

Experience

Artemis Hospital

Hospital

1500

Fees

View Details
Dr. Shelly Mittal

Dr. Shelly Mittal

Sr. Consultant

Medical Oncology & Hematology

New Delhi

14+ Years

Experience

Artemis Hospital

Hospital

1500

Fees

View Details
Dr. Hari Goyal

Dr. Hari Goyal

Director

Medical Oncology & Haemato-Oncology

New Delhi

34+ Years

Experience

Apolo Delhi

Hospital

1500

Fees

View Details

Related Links

Ready To Start Your Healing Journey?

Get Personalized Medical Treatment Options From India's Top Hospitals. Our Medical Experts Are Ready To Assist You Every Step Of The Way.